A Microfluidic Device to Advance Field-Testing for Biological Samples

Source: Tech Briefs, by SAE Media Group. AI-generated summary by biochip.com, published April 11, 2026. Not independently reviewed.

Sandia researchers have developed a portable microfluidic immunoassay device designed to detect proteins in biological samples outside a conventional laboratory. The system automates steps that would otherwise be performed manually, reducing its need for bulky instruments and specially trained technicians. It is intended to deliver a result in about 40 minutes, from introducing a sample to receiving an answer. That faster sample-to-answer workflow could be valuable when samples must be analyzed near where they are collected rather than transported to a central lab. The device is built around a microfluidic chip, a small platform that directs tiny volumes of liquid through designated chambers. Users load the needed test reagents and a sample, seal the chip, and insert it into the device. Electromagnetic controls move a permanent magnet to manipulate magnetic components inside the system. Sandia sees the platform as a potential tool for detecting protein markers linked to inflammation and infectious disease in the field.

Bringing the Test to the Sample

Many biological tests follow a familiar routine: collect samples, ship them to a laboratory, wait until enough samples accumulate, and run them in a batch. That approach can make sense for high-throughput testing, but it can add delays and transportation costs when a result is needed quickly.

Sandia's device reverses that workflow by taking the analytical platform to the sample. Rather than transporting a potentially infectious specimen to a laboratory, an operator could analyze it at the collection site. The intended benefit is not simply portability, but a shorter path between sample collection and a usable result.

A Lab Workflow on a Small Chip

Microfluidics is the control of liquids in extremely small channels and chambers. A useful everyday comparison is a miniature plumbing system: instead of pipes carrying water through a house, tiny pathways guide reagents and biological samples through a compact test cartridge.

For this system, the operator introduces the reagents required for the test into the appropriate chamber, adds the sample, seals the microfluidic chip, and inserts it into the instrument. The device then automates the testing process. This simplified sequence is meant to remove manual handling steps that can otherwise require skilled laboratory personnel.

How Magnetic Control Supports Automation

The platform uses a permanent magnet that moves under electromagnetic control. In practical terms, electromagnets allow the device to reposition the magnet as needed, letting it manipulate magnetic material within the chip. That controlled movement is part of how the system carries out its automated assay process.

An immunoassay is a test format used to detect a biological target, such as a protein. Here, the stated target is protein markers associated with inflammation levels in the body, which could support testing for infectious disease. The device's value lies in coupling that type of biological measurement with a portable, automated microfluidic workflow.

Why Forty Minutes Matters

Sandia reports a sample-to-answer time of 40 minutes. That phrase refers to the full interval from placing the sample into the testing process to obtaining the result, rather than only the time spent on one measurement step.

The timing also changes how samples can be processed. Instead of waiting to collect a group of samples for parallel laboratory analysis, the device is intended to support a collect-and-run approach. For field settings, that could reduce the delay created by storage, transport, and batch scheduling.

Why This Matters

Portable testing systems can be especially useful when laboratory infrastructure is distant, sample transport is difficult, or handling infectious material creates logistical burdens. By combining a sealed microfluidic chip with automated magnetic control, Sandia's platform aims to make protein detection more accessible beyond centralized testing facilities.

The device also illustrates a broader goal for lab-on-a-chip technology: shrinking not just the physical size of an assay, but the operational complexity around it. A compact instrument is most useful when an operator can prepare a sample, load a cartridge, and obtain a result without needing a large laboratory setup.

What Comes Next

Sandia describes the technology as still being developed, while emphasizing its potential impact in field use. Its future usefulness will depend on how the platform performs across the infectious-disease tests and biological samples it is designed to address. If it can retain accurate protein detection while simplifying field operation, the device could offer a practical alternative to sending every sample back to a centralized lab.

Topics: Microfluidics · Diagnostics & precision medicine · Infectious diseases

Start here: Microfluidics explained